TY - JOUR T1 - Pre-exposure prophylaxis acceptability among transgender women in the UK JF - BMJ Sexual & Reproductive Health JO - BMJ Sex Reprod Health DO - 10.1136/bmjsrh-2020-200733 SP - bmjsrh-2020-200733 AU - Ella G Brown AU - Kevin Deane Y1 - 2020/10/14 UR - http://jfprhc.bmj.com/content/early/2020/10/14/bmjsrh-2020-200733.abstract N2 - After years of campaigning and controversy, the Department of Health recently announced that they will begin routine commissioning of pre-exposure prophylaxis (PrEP) in England, meaning that free at the point of access PrEP is available in all regions of the UK. This is an important step forward in the UK’s aim to reach zero transmissions by 2030. Global data have shown that transgender women (TGW) are disproportionately affected by HIV.1 This can be attributed to a plethora of intersecting risk factors and vulnerabilities, many of which stem from the systemic and enacted discrimination, stigma and marginalisation that TGW experience.2 Given their increased risk, PrEP could be a valuable tool for TGW, especially given that risk factors such as involvement in sex work, sexual violence, and diminished sexual agency often preclude condom use.2 However, … ER -